Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Evaluation of Genetic and Epigenetic Alterations in Patients With Thoracic Malignancies

NCT00242723 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT00242723
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00242723 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Evaluation of Genetic and Epigenetic Alterations in Patients With Thoracic Malignancies
Lead sponsor
National Cancer Institute (NCI)
Phase
Observational
Overall status
Recruiting
Start date
November 9, 2005
Completion date
Not reported
Enrollment
1,559 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancers of non thoracic origin with metastases to the lungs or pleura, esophageal cancers nos, lung cancer nos, malignant pleural mesotheliomas nos, thoracic cancers, thoracic malignancies